BDNF (P21)
CognitiveCognitive Enhancement / Neurotrophic PeptideExperimental
CNTF analog for BDNF research in cognition.
For research use only.
Key Facts
- CAS
- —
- Molecular Weight (MW)
- ~1,800 g/mol
- Half-life
- 1–2 hours
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- Daily
- Last updated
- 12/18/2025
- Targets
- BDNF-TrkB
Overview
CNTF analog for BDNF research in cognition.
Protocol
- Dosage Range
- 200–500 mcg
- Frequency
- Daily
- Cycle
- 6–8 weeks on, 2–4 off
- Administration Route
- Subcutaneous
- Reconstitution Guide
- 2 mL BAC for 10 mg vial
Science
Mechanism of Action
BDNF upregulation, LTP enhancement.
Targets
BDNF-TrkB
Studies
- — Journal/year not available
Benefits
FocusMemoryNeuroplasticityMood stability
Potential Side Effects
- Headache
- Fatigue